Rock Springs Capital Management’s Immunomedics Inc IMMU Stock Holding History

Rock Springs Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,587,500	Closed	-$135M	–	167
2020 Q3	$135M	Sell	1,587,500 -90,179	-5%	-$4.56M	3.43%	3
2020 Q2	$59.5M	Buy	1,677,679 +627,679	+60%	+$18.4M	1.63%	11
2020 Q1	$14.2M	Buy	1,050,000 +50,000	+5%	+$841K	0.59%	58
2019 Q4	$21.2M	Buy	1,000,000 +105,000	+12%	+$1.85M	0.67%	59
2019 Q3	$11.9M	Hold	895,000	–	–	0.47%	66
2019 Q2	$12.4M	Buy	895,000 +95,000	+12%	+$1.43M	0.45%	74
2019 Q1	$15.4M	Buy	800,000 +20,000	+3%	+$322K	0.59%	56
2018 Q4	$11.1M	Buy	780,000 +5,000	+0.6%	+$99.3K	0.53%	62
2018 Q3	$16.1M	Buy	775,000 +275,000	+55%	+$6.51M	0.58%	61
2018 Q2	$11.8M	Buy	500,000 +50,000	+11%	+$1M	0.46%	74
2018 Q1	$6.58M	Buy	+450,000	New	+$7.35M	0.28%	99

Rock Springs Capital Management's IMMU Position: Q4 2020 in Review

Rock Springs Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,587,500 shares — an estimated $135M sold.

Rock Springs Capital Management first reported a position in IMMU in Q1 2018 and held it in 11 quarters. The position peaked at $135M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Rock Springs Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Rock Springs Capital Management sold 1,587,500 Immunomedics Inc shares in Q4 2020, an estimated $135M.
Rock Springs Capital Management first reported a position in Immunomedics Inc in Q1 2018 and held it in 11 quarters.
Rock Springs Capital Management's Immunomedics Inc position peaked at $135M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Rock Springs Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.